Company performance
Add to research
Current Price
as of Mar 20, 2025$109.41
P/E Ratio
N/A
Market Cap
$2.08B
Description
Add to research
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.
Metrics
Add to research
Overview
- HQJupiter, FL
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerLGND
- Price$109.41+1.28%
Trading Information
- Market cap$2.08B
- Float97.53%
- Average Daily Volume (1m)139,956
- Average Daily Volume (3m)107,186
- EPS-$0.22
Company
- Revenue$167.13M
- Rev growth (1yr)27.28%
- Net income-$4.03M
- Gross margin72.28%
- EBITDA margin36.14%
- EBITDA$60.41M
- EV$1.71B
- EV/Revenue10.24
- P/EN/A
- P/S11.97
- P/B2.52
- Debt/Equity0.86
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account
Wikipedia